Thermo Fisher Scientific (TMO) Specialty Diagnostics — Research and development expenses — Quarterly & Annual

Screener

Other segment segments

Analytical Instruments

$139M+1.5%

Life Sciences Solutions

$131M-5.8%

Laboratory Products and Biopharma Services

$15M+15.4%

Similar metrics at other companies

SOL

SOLSElectronic & Specialty Materials — Research and development expenses

$10M+11.1%

AVN

AVNSTotal Specialty Nutrition Systems — Research and development expenses

-$3.7M+9.8%

TWIConsumer — Research and development expenses

$1.01M+13.3%

TWIAgriculture — Research and development expenses

$1.49M+9.7%

BAXPharmaceuticals — Research and development expenses

$22M-15.4%

CNHAgriculture — Research and development expenses

$205M+25.8%

Other financials

Income statement

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

Market cap$213.65B+26.0%

Enterprise value$248.77B+22.9%

P/E30.7×+4.9×

P/S4.8×-0.9×

Profitability

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000097745-26-000092

(In millions)	Life Sciences Solutions	Analytical Instruments	Specialty Diagnostics	Laboratory Products and Biopharma Services	Total
Segment Income
Cost of revenues	1,004	876	657	4,757
Selling, general, and administrative expenses	496	313	177	597
Research and development expenses	131	139	44	15
Other segment items	50	34	(49)	(110)
Segment income	954	355	313	778	2,399
Unallocated amounts
Cost of revenues adjustments					(14)

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's specialty diagnostics — research and development expenses?: Thermo Fisher Scientific (TMO) reported specialty diagnostics — research and development expenses of $44M in Q1 2026.
How has Thermo Fisher Scientific's specialty diagnostics — research and development expenses changed year-over-year?: Thermo Fisher Scientific's specialty diagnostics — research and development expenses decreased by 2.2% year-over-year, from $45M to $44M.
What does specialty diagnostics — research and development expenses mean?: Expenditures dedicated to the discovery, development, and improvement of new diagnostic technologies, reagents, and clinical testing solutions within the Specialty Diagnostics segment. This reflects the segment's commitment to innovation and future product pipelines.

Ask your AI about Thermo Fisher Scientific's specialty diagnostics — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk